The Food and Drug Administration recently approved Pivya (pivmecillinam) to treat uncomplicated UTIs in female adults.

Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the ...

Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and older.

New evidence from the World Health Organisation (WHO) shows the extensive overuse of antibiotics during the COVID-19 pandemic ...

The U.S. Food and Drug Administration has approved Pivya (pivmecillinam) tablets for the treatment of female adults with ...

A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...

"The FDA is committed to fostering new antibiotic availability when they prove to be safe and effective, and Pivya will ...

Transfer of bacteria between sick pets and their humans may be contributing to antibiotic resistance, according to new ...

A meta-analysis of genetic studies analyzing the microbiota (bacteria in the gut) of 1,275 infants from 10 countries finds ...

Prescriptions for broad-spectrum antibiotics fell when clinicians were intercepted by a risk-assessment prompt.

Use of antibiotics for acute sinusitis in children reduces treatment failures, a meta-analysis showed, but the results may ...

Intranasal administration of neomycin sulfate in murine models shows promise as a prophylactic and therapeutic agent against ...